Zobrazeno 1 - 10
of 2 020
pro vyhledávání: '"ulinastatin"'
Autor:
Yi-Ran He, Ni Ding, Ming-Chen Han, Hong-Yu He, Li-Zhen Xuan, Zhun-Yong Gu, Ming Zhong, Min-Jie Ju
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Introduction Sepsis and cancer are both leading causes of death worldwide, and they share several pathophysiological characteristics. Some studies have suggested a possible association between sepsis and cancer; however, few have investigate
Externí odkaz:
https://doaj.org/article/fdbc41ba050540d486341c20112bdff1
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 5897-5905 (2024)
Kai Wang, Jihong Zhu, Weibo Gao, Wei Guo, Yang Guo Department of Emergency, Peking University People’s Hospital, Beijing, 100044, People’s Republic of ChinaCorrespondence: Yang Guo; Wei Guo, Email edguoyang@163.com; woaiguowei111@sina.comBackgrou
Externí odkaz:
https://doaj.org/article/f7ef8a7bcb0b4262a58a04a09bf0d985
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 11, Pp 1674-1679 (2024)
Objective To investigate the effect of ulinastatin (UTI) on the level of oxidative stress as well as intestinal flora in rats with sepsis-induced acute lung injury (ALI), providing theoretical support for the diagnosis and treatment of sepsis-induced
Externí odkaz:
https://doaj.org/article/29d75b665b8c4ec4a05fe3d45046a2a1
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract This study aimed to assess the influence of ulinastatin (UTI) on lymphocyte apoptosis and autophagy in sepsis patients, as well as its effect on inflammatory factors and vital organ function, with the goal of providing insights for improved
Externí odkaz:
https://doaj.org/article/28eda33e46784eea8e386a36672b47e5
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Renal fibrosis is a common outcome of chronic kidney diseases and glycolysis drives the development of renal fibrosis in damaged kidneys. Ulinastatin (UTI) is a broad-spectrum protease inhibitor with anti-inflammatory and antioxidant propert
Externí odkaz:
https://doaj.org/article/5bb425185a664626a617f223bfd9f669
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 8753-8773 (2024)
Wen Hu,1,* Xiaoyuan Zhang,1,* Zhen Wu,1,* Yushan Luo,1,* Bailong Hu,2 Xiaohua Zou2 1Guizhou Medical University, Guiyang, Guizhou, 550004, People’s Republic of China; 2Department of Anesthesiology, The Affiliated Hospital of Guizhou
Externí odkaz:
https://doaj.org/article/f06008975e4946158969ab16e0387e92
Publikováno v:
Journal of Pain Research, Vol Volume 17, Pp 2571-2584 (2024)
Chunliu Hou,1,* Ying Liu,2,* Xuesen Su,1 Shouyuan Tian,1 Yan Li1,2 1College of Anesthesia, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 2Department of Anesthesiology, Tianjin Jizhou People’s Hospital, Tianjin, P
Externí odkaz:
https://doaj.org/article/5607fa23b03e40c5865ab477f51f607d
Publikováno v:
Heliyon, Vol 10, Iss 19, Pp e38050- (2024)
Objective: The NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome-driven immune-inflammatory response has been shown to play a critical role in epilepsy progression across multiple studies. While Ulinastatin (UTI), an immunomodu
Externí odkaz:
https://doaj.org/article/5622bab567e54babb9e63abd0c0d1e70
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Objective This comparative analysis aimed to investigate the efficacy of Sivelestat Sodium Hydrate (SSH) combined with Ulinastatin (UTI) in the treatment of sepsis with acute respiratory distress syndrome (ARDS). Methods A control group and
Externí odkaz:
https://doaj.org/article/8ce6b3819d8f4055ad92d1f6ae981e4c
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Ulinastatin, an anti-inflammatory and antioxidant trypsin inhibitor, has shown potential in mitigating acute kidney injury (AKI) and reducing serum creatinine levels after various surgeries. This retrospective study aimed to evalu
Externí odkaz:
https://doaj.org/article/8e6858f550a64021a3e4db66e8eacd2b